Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Luminex Corporation    LMNX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/10/2017 08/11/2017 08/14/2017 08/15/2017 08/16/2017 Date
19.21(c) 19.19(c) 19.43(c) 19.3(c) 19.19(c) Last
144 574 278 696 145 020 95 190 115 612 Volume
-3.71% -0.10% +1.25% -0.67% -0.57% Change
More quotes
Financials ($)
Sales 2017 305 M
EBIT 2017 35,1 M
Net income 2017 25,2 M
Finance 2017 103 M
Yield 2017 1,24%
Sales 2018 315 M
EBIT 2018 49,7 M
Net income 2018 33,0 M
Finance 2018 131 M
Yield 2018 1,35%
P/E ratio 2017 35,74
P/E ratio 2018 25,06
EV / Sales2017 2,45x
EV / Sales2018 2,29x
Capitalization 851 M
More Financials
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. 
More about the company
Surperformance© ratings of Luminex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on LUMINEX CORPORATION
08/08 LUMINEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
08/08 LUMINEX : tops Street 2Q forecasts
08/07 LUMINEX CORP : Results of Operations and Financial Condition, Financial Statemen..
08/07 LUMINEX CORPORATION (NASDAQ : LMNX) Files An 8-K Results of Operations and Finan..
08/03 LUMINEX CORPORATION : Receives FDA Clearance for ARIES C. difficile Assay
08/02 LUMINEX : Combine Solicitation - Milliplex FlexMap 3D system
08/02LUMINEX CORPORATION : half-yearly earnings release
07/25 LUMINEX : Special Notice - 711th Project
07/24 LUMINEX : Combined Synopsis/Solicitation - Luminex microspheres
07/24 LUMINEX : Combine Solicitation - Luminex microspheres
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/03DJHot Stocks to Watch in the U.S. and Canada
08/01DJAthenahealth Makes a Shareholder-Backed Shake-Up, Keeping CEO
07/24 Autos, airlines hit in sluggish start to European trading week
07/24 ROYAL PHILIPS : Philips targets order book growth of 4-6 percent in 2017 - CEO
07/24DJROYAL PHILIPS : 2Q Net Profit Rises; Begins EUR1.5 Billion Share Buyback Program
More sector news : Advanced Medical Equipment & Technology - NEC
Latest Tweets
08/16State Street Corp Raises Position in Luminex Corporation $LMNX  
08/14Want the latest analyst ratings on $TWGP $CPYYY $AVDL $LMNX $ELNK? Get Them D.. 
08/09Luminex Corporation downgraded by TheStreet to c+.  
08/08$LMNX ALERT: New Luminex Corp SEC Filing From our Stock News Alerts App 
08/08Luminex Corporation Reports Second Quarter 2017 Financial Results  
More tweets
Qtime:12
News from SeekingAlpha
08/07 Luminex's (LMNX) CEO Homi Shamir on Q2 2017 Results - Earnings Call Transcrip..
08/07 Luminex beats by $0.16, beats on revenue
08/06 Notable earnings after Monday?s close
07/24 FDA clears Luminex's ARIES C. diff assay
06/28 Luminex receives CE-IVD mark for ARIES Norovirus Assay
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Technical analysis trends LUMINEX CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 20,6 $
Spread / Average Target 6,7%
EPS Revisions
Managers
NameTitle
Nachum Shamir President, Chief Executive Officer & Director
G. Walter Loewenbaum Chairman
Harriss T. Currie Chief Financial Officer, Treasurer & SVP-Finance
Tadd S. Lazarus Chief Medical Officer & Senior Vice President
Thomas W. Erickson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LUMINEX CORPORATION-4.60%851
THERMO FISHER SCIENTIFIC INC.23.01%69 232
DANAHER3.49%55 964
INTUITIVE SURGICAL55.38%36 607
BOSTON SCIENTIFIC CORPORATION22.38%36 320
ROYAL PHILIPS9.52%35 080